- Drug not currently available for use in the U.S.
- Also known in the literature as entamide furoate or entamide.
- CDC conducted a study on the investigational use of the drug between 1977-1990.
NON-FDA APPROVED USES
- Amebiasis, limited to the GI lumen, caused by Entamoeba histolytica.
- As a combination therapy with other antiprotozoals, such as nitroimidazoles, for treating invasive or extraintestinal amebiasis. Diloxanide furoate is not a tissue amoebicide. Therefore, in extraintestinal infections of E. histolytica, another agent (specifically a "tissue amoebicide" like metronidazole) should be considered for use with diloxanide furoate.
There's more to see -- the rest of this topic is available only to subscribers.